Table 1. Association between miR-214 expression and clinicopathological parameters in 80 primary gastric cancer samples.
| Variable | Number | Median | P-value |
| Age (y) | |||
| ≤61 | 36 | 0.02127 | 0.037 |
| >61 | 44 | 0.01265 | |
| Sex | |||
| Male | 65 | 0.01543 | 0.0962 |
| Female | 15 | 0.01405 | |
| Clinical Stage | |||
| I | 14 | 0.01343 | 0.2791 |
| II | 17 | 0.01222 | |
| III | 24 | 0.02409 | |
| IV | 25 | 0.01553 | |
| Tumour size (mm) | |||
| ≤30 | 17 | 0.03673 | 0.0265 |
| >30 | 63 | 0.01468 | |
| Lymph node metastasis | |||
| Metastasis | 44 | 0.01391 | 0.0164 |
| Nonmetastasis | 36 | 0.02476 | |
| Distal metastasis | |||
| Positive | 15 | 0.01553 | 0.4151 |
| Negative | 65 | 0.01534 | |
| WHO histological classification | |||
| Well-differentiated | 4 | 0.02749 | 0.1054 |
| Moderately differentiated | 25 | 0.01053 | |
| Poorly differentiated | 41 | 0.01534 | |
| Mucinous adenocarcinoma | 10 | 0.02492 | |
| Lauren's classification | |||
| Intestinal type | 23 | 0.01422 | 0.3567 |
| Diffuse type | 57 | 0.01553 | |
| Relapse status | |||
| Relapse group | 47 | 0.01553 | 0.1512 |
| Nonrelapse group | 33 | 0.01278 | |
| Prognosis | |||
| Survival group | 34 | 0.0131 | 0.1363 |
| Death group | 46 | 0.01634 | |
| Total | 80 | 0.01501 |